SNN - Smith & Nephew plc

NYSE - NYSE Delayed price. Currency in USD
34.99
+0.27 (+0.78%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous close34.72
Open35.08
Bid0.00 x 0
Ask0.00 x 0
Day's range34.90 - 35.12
52-week range29.76 - 40.43
Volume546,209
Avg. volume492,240
Market cap14.233B
Beta0.46
PE ratio (TTM)17.82
EPS (TTM)1.96
Earnings dateN/A
Forward dividend & yield0.62 (1.77%)
Ex-dividend date2017-10-05
1y target est41.58
Trade prices are not sourced from all markets
  • Globe Newswire8 days ago

    The Steadman Clinic, SPRI and Smith & Nephew Host Annual Vail Hip Symposium

    The Steadman Clinic (TSC) and the Steadman Philippon Research Institute, (SPRI) have joined with host Smith & Nephew to present the 2018 Vail Hip Symposium, a three-day event beginning Thursday, Jan. 11 at the Westin Riverfront Resort & Spa at Beaver Creek. Dr. Marc J. Philippon, Managing Partner of The Steadman Clinic and Co-Chairman of SPRI and one of the leading hip specialists in the industry, has directed SPRI’s efforts in this event since its inception.

  • Smith & Nephew's Rotation Medical Deal Aids Tissue Regen Arm
    Zackslast month

    Smith & Nephew's Rotation Medical Deal Aids Tissue Regen Arm

    Smith & Nephew's (SNN) completion of Rotation Medical acquisition appears highly strategic as this will consolidate the company's position in disruptive technologies and advance its overall growth.

  • Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care
    Business Wirelast month

    Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care

    LONDON--(BUSINESSWIRE)-- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the European launch of MolecuLight i :X TM , the easy to use, handheld imaging device ...

  • Business Wirelast month

    Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care

    Smith & Nephew , the global medical technology business, today announces the European launch of MolecuLight i:XTM, the easy to use, handheld imaging device

  • Will a 'Huge Tax Cut' Ease Burden for MedTech Players?
    Zacks2 months ago

    Will a 'Huge Tax Cut' Ease Burden for MedTech Players?

    How is the MedTech industry placed in the wake of the current political conundrum surrounding tax reforms?

  • Stocks Generating Improved Relative Strength: Smith & Nephew
    Investor's Business Daily2 months ago

    Stocks Generating Improved Relative Strength: Smith & Nephew

    Smith & Nephew shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

  • Smith & Nephew Shows Improved Relative Price Performance; Still Shy Of Benchmark
    Investor's Business Daily3 months ago

    Smith & Nephew Shows Improved Relative Price Performance; Still Shy Of Benchmark

    Smith & Nephew shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

  • Why MannKind, Nutanix, and Smith & Nephew Jumped Today
    Motley Fool3 months ago

    Why MannKind, Nutanix, and Smith & Nephew Jumped Today

    On a sunny day for the market, these stocks gained ground. Find out why.

  • Reuters3 months ago

    Elliott Management builds stake in Smith & Nephew - Bloomberg

    It is unclear how much stake the activist investor owns or what it plans to push for at the company, according to the Bloomberg report. "We do not comment on rumour or speculation and we do not comment on the identity of our investors other than those publicly disclosed," Smith & Nephew said in an emailed statement. Elliott declined to comment.

  • Elliott's Deal Magic Is Put to the Test
    Bloomberg3 months ago

    Elliott's Deal Magic Is Put to the Test

    The hedge fund has taken a stake in Smith & Nephew, which year after year has disappointed M&A speculators.

  • Singer's Elliott Builds a Stake in Smith & Nephew
    Bloomberg3 months ago

    Singer's Elliott Builds a Stake in Smith & Nephew

    Billionaire Paul Singer’s hedge fund Elliott Management Corp. has built a stake in Smith & Nephew Plc, the maker of artificial hips and knees, according to people familiar with the matter.

  • Stocks Showing Improved Relative Strength: Smith & Nephew
    Investor's Business Daily4 months ago

    Stocks Showing Improved Relative Strength: Smith & Nephew

    Smith & Nephew shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

  • Graham-Cassidy Fail Shines Spotlight on 3 Top Dividend Stocks
    Zacks4 months ago

    Graham-Cassidy Fail Shines Spotlight on 3 Top Dividend Stocks

    Zeroing in on dividend stocks with a solid Zacks Rank is a great way to increase the chances of beating volatile market conditions while ensuring a steady stream of cash flow. Here are three top picks in the MedTech space.

  • Reuters - UK Focus6 months ago

    Smith & Nephew buoyed by double-digit emerging markets growth

    Artificial hip and knee maker Smith & Nephew (Frankfurt: 502816 - news) reported a 3 percent rise in underlying revenue growth in the second quarter, in line with its 3-4 percent forecast for the year, helped by 13 percent growth in emerging markets. Chief Executive Olivier Bohuon said on Thursday the company was seeing good momentum, keeping it on track to deliver on full year revenue and trading margin guidance. Smith & Nephew, which competes against larger U.S. rivals in the orthopaedic replacement market, is battling to bring new technology on-stream to help it win business, with robotics a key area of innovation.

  • Reuters - UK Focus7 months ago

    Robot wars: knee surgery marks new battleground for companies

    The world's top medical technology companies are turning to robots to help with complex knee surgery, promising quicker procedures and better results in operations that often leave patients dissatisfied. Demand for artificial replacement joints is growing fast, as baby boomers' knees and hips wear out, but for the past 15 years rival firms have failed to deliver a technological advance to gain them significant market share.

  • Business Wire8 months ago

    Study results demonstrate 74% reduction in surgical site infections with use of PICO™ Single use Negative Pressure Wound Therapy system

    LONDON--(BUSINESSWIRE)-- Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, proudly supports results of an independent, randomised clinical trial 1 concluding that, in the patients ...

  • Reuters - UK Focus9 months ago

    Emerging markets growth puts Smith & Nephew on track for year

    Shares in Smith & Nephew (Frankfurt: 502816 - news) rose to a nine-month high on Friday after the artificial hip and knee maker said a strong first quarter, led by growth in emerging markets, put it on track to meet it targets for the year. The company reported underlying revenue growth of 3 percent, within the 3-4 percent range it has forecast for the year, in what analysts said was likely to be its weakest quarter. Chief Executive Olivier Bohuon said the company had made a good start to the year, highlighting emerging markets, where growth returned to double-digits, with China up by an underlying 14 percent.

  • Reuters - UK Focus9 months ago

    Smith & Nephew says M&A 'not at top of agenda' at the moment

    The chief executive of Smith & Nephew said on Friday that M&A was not at the top of his agenda, as the focus was on driving growth at the artificial knee and hip maker. A report in the Financial Times in March said Wright Medical , a U.S. company that specialise in surgical implants for extremities like feet and ankles, could be a takeover target for the British company. S&N Chief Executive Olivier Bohuon said M&A was "always on the agenda", and he had previously pointed to extremities as one of a number of areas of interest.

  • Reuters - UK Focus9 months ago

    Smith & Nephew Q1 revenue rises 3 pct on underlying basis

    Smith & Nephew, Europe's biggest artificial hip and knee maker, reported a 3 percent rise in underlying revenue in its first quarter, helped by a return to double-digit growth in emerging markets and a ...

  • Elliott Said to Build Stake in Smith & Nephew
    Bloomberg Video3 months ago

    Elliott Said to Build Stake in Smith & Nephew

    Oct.11 -- Activist investor Paul Singer is honing in on Europe, building stakes in an engineering and healthcare company. An after hour statement revealed Singer's hedge fund Elliott Management added German engineering firm GEA to its portfolio and according to people familiar with the matter, it also took a stake in the British company Smith & Nephew. Bloomberg's Ruth David reports on "Bloomberg Markets: European Open."

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes